Deregulated Gab2 Phosphorylation Mediates Aberrant AKT and STAT3 Signaling Upon PIK3R1 Loss in Ovarian Cancer

Nature Communications - United Kingdom
doi 10.1038/s41467-019-08574-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Selective FGFR Inhibitor BGJ398 Inhibits Phosphorylation of AKT and STAT3 and Induces Cytotoxicity in Sphere-Cultured Ovarian Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2017English

STAT3 Signaling in Ovarian Cancer: A Potential Therapeutic Target

Journal of Cancer
Oncology
2020English

Phosphorylation of STAT3 at Tyr705 Regulates MMP-9 Production in Epithelial Ovarian Cancer

PLoS ONE
Multidisciplinary
2017English

Indirubin Suppresses Ovarian Cancer Cell Viabilities Through the STAT3 Signaling Pathway

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Resveratrol Suppresses Colon Cancer Growth by Targeting the AKT/STAT3 Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer

Cancers
Cancer ResearchOncology
2019English

Matrine Inhibits the Development and Progression of Ovarian Cancer by Repressing Cancer Associated Phosphorylation Signaling Pathways

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Targeting Constitutively-Activated STAT3 in Hypoxic Ovarian Cancer, Using a Novel STAT3 Inhibitor

Oncoscience
Cancer ResearchOncology
2014English

Stathmin Gene Silencing Suppresses Proliferation, Migration and Invasion of Gastric Cancer Cells via AKT/sCLU and STAT3 Signaling

International Journal of Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy